Hearing loss genetic disease is a new born hereditary issue passing from parents to children, screening of this test may be useful for any severe cases
Hearing loss genetic disease is a new born hereditary issue passing from parents to children, screening of this test may be useful for any severe cases
Opportunities for kids with Hearing loss dougbackous
This is a short review of new opportunities for children with hearing loss aimed at primary care doctors. Parents can learn from it as well. Presented at the Swedish Pediatric education 1/21/11.
Opportunities for kids with Hearing lossdougbackous
This is a short review of new opportunities for children with hearing loss aimed at primary care doctors. Parents can learn from it as well. Presented at the Swedish Pediatric education 1/21/11.
Hearing loss is one of the most frequent sensory deficient in human population. It affects more than 360 million people.
Consequences of hearing impairment include reduced ability to communicate, economic and educational disadvantage, social isolation and stigmatization.
we will talk also about the common types & causes of hearing loss and the possible applicable methods to treat these conditions.
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
Evaluation of deaf child
1. EVALUATION OF DEAF CHILD
Dr.Poongkamali J
MS ENT-HNS, PG 1yr
AIIMS, Bhopal
2. DEFINITION
o Deaf: A term (with a capital D) used by some people who have little or no useful residual hearing to identify
themselves as members of Deaf Culture
o deaf: A term (with a lower-case d) used in this report to describe people who have little or no useful residual
hearing (i.e., severe or profound hearing loss), whether or not they identify themselves as Deaf.
o Hearing loss: Hearing threshold >25 db.
o Disabling hearing loss: > 30 db in children
o Hard of hearing: mild to severe hearing loss
o Deafness: profound hearing loss
3. WHO/INDIAN CONSTITUTION DEFINITION
WHO DEFINITION
o Deafness- refers to the complete loss of hearing ability in one or two ears.
The cases included in this category will be those having hearing loss more than 90dB
in better ear (profound impairment) or total loss of hearing in both the ears, i.e. profound hearing loss
o Hearing impairment- refers to both complete and partial loss of ability to hear.
ACCORDING TO INDIAN CONSTITUTION
o Hearing handicapped –Hearing impairment of 70dB and above, in better ear or
total loss of hearing in both ears (The Rehabilitation Council of India Act, 1992)
o Hearing disability has been redefined as – a hearing disable person is one who has the hearing loss of 60dB
or more in the better ear for conversational range of frequencies & person with disability means a person suffering from not less than 40%
of any disability as certified by a medical authority. (Section 2(i)(iv) of the persons with Disability Act, 1995)
4. Global Burden
Over 5% of the world’s population – or 466 million people – has disabling hearing loss (432 million adults and
34 million children).
The prevalence of deafness in South-East Asia ranges from 4.6% to 8.8%.
In 2005 WHO estimates-India, 63 million people (6.3%) suffer from significant auditory loss. Four in every 1000
children suffer from severe to profound hearing loss. With over 100,000 babies that are born with hearing
deficiency every year
The National Sample Survey 58th round (2002) surveyed disability in Indian households and found that hearing
disability was the 2nd most common cause of disability and top most cause of sensory deficit.
World over, hearing loss is the second leading cause for ‘Years lived with Disability (YLD)’
60 % of childhood hearing loss is preventable with 75% in developing countries.
5. IMPACT OF HEARING LOSS
Functional impact- delay in development of receptive & expressive communication skills( speech& language)
Social and emotional impact- communication difficulties leads to social isolation, loneliness, frustration and poor
self regard
Academic impact – learning problems that results in reduced academic achievement.
Economic impact- much higher rates of unemployment or very lower grades of employment with adds on to
decreased productivity along with the costs incurred in educational costs, health sector costs and other
vocational supports.
10. NATAL HISTORY
ANTENATAL HISTORY
o Anomaly scans
o Immunization status
o TORCH infections
o Environmental hazards/ototoxic
drugs/teratogenic agents
o Perinatal infections/PROM/
prolonged labour/
hypothyroidism/gestational
diabetes & other medical
conditions
INTRANATAL HISTROY
o Term/pre term
o Place /mode of delivery
o Birth weight/ APGAR
o Congenital anomalies
o Birth weight <1500gms
POSTNATAL HISTORY
o NICU/PICU stay
o Neonatal jaundice required blood
transfusion
o Exanthematous fever
o Encephalitis/ meningitis
o ENT in infections/noise
exposure/ototoxic drugs
o Blood transfusion/ hospital
admissions
o Immunization details
13. CLINICAL EXAMINATION
ENT - wax/perforation/canal atresia/adenoids/
tongue tie/cleft lip palate…..
VISION
Integumentary changes
I/Q, D/Q assessment
PEDIATRIC ASSESSMET- for complete milestone assessment/
neurological development/
associated congenital anomalies
CAUSES OF CHL
CONGENITAL
• Microtia/atresia
• Ossicular malformations
• Cholesteatoma
ACQUIRED
• Infection
• Otitis media with effusion
• Foreign body
• Trauma
14. AUDIOLOGICAL TESTS
BEHAVIOURAL RESPONSE AUDIOMETRY(0-6 MONTHS)
1. Moro’s reflex
2. Cochleopalpebral reflex
3. Cessation reflex
Has been largely superseded by availability of electrophysiological techniques but, may be useful in auditory spectrum disorder or retro cochlear lesion
where ABR will be of little use.
DISTRACTION TEST (6 – 18 months)
CONDITIONING TECHNIQUES (7months- 2 years)
1. Visual reinforcement audiometry
2. Play audiometry
OBJECTIVE TESTS
1. ABR
2. OAE
3. Impedance audiometry
SPEECH DISCRIMINATION TEST
15. INVESTIGATIONS CONTD….
OTHER TESTS
o Echocardiography/ ECG
o USG KUB & abdomen
o TFT
o Ophthalmic assessment of
vision and fundus
o Serological tests
o Immunological tests
o Metabolic and
chromosomal studies
RADIOLOGICAL TESTS
o HRCT temporal bone
o MRI brain with 3D
reconstruction with 8 th nerve
complex
17. SCREENING OF HEARING
HNHS
“High risk Neonatal Hearing Screening”
Babies born out of high risk pregnancies are
screened.
Specificity is 50% only
Cost effective protocol
UNHS
“Universal neonatal hearing screening”
All births are screened for hearing impairment
within 48 hrs of birth
Almost specificity is 100%
High cost expenditure.
18. HIGH RISK REGISTER
H/O inutero infections
H/O ototoxic drug use by mother during pregnancy
Alcohol intake
Prolonged/hazardous labour
NICU admission >/- 48 hrs in first 4 weeks of life
Birth weight <1500 grams
APGAR below 4 at 1 minute and below 6 at 5 minutes of
birth
Any recognizable syndrome
Family h/o permanent marked SNHL
Craniofacial anomalies
Born out of consanguineous marriage
Parental concern regarding speech, language and hearing
Delayed developmental milestones
Identification of any syndrome which has late onset hearing loss
H/O postnatal infection, neonatal conditions like hyperbilirubinemia
H/O head trauma
Recurrent and persistent otitis media with effusion for 3 months
Ambiguous neonatal screening tests results
Joint Committee on Infant Hearing 1994 Position Statement – Joint Committee on Infant Hearing, American Academy Of
Pediatrics January 1995, 95 (1) 152-156;
19. SCREENING FLOWCHART
SCREENING (Universal+ High risk)- OAE with 48 hrs.
If normal – normal hearing
If abnormal – recheck after 5-7 days
If abnormal- BERA
BERA normal- middle ear pathology
BERA Abnormal- Intervention.
20. REFERENCES:
https://www.who.int/news-room/fact-sheets/detail/deafness-and-hearing-loss
https://www.who.int/data/gho/publications/world-health-statistics
Varshney S. Deafness in India. Indian J Otol 2016;22:73-6
National Research Council (US) Committee on Disability Determination for Individuals with Hearing Impairments; Dobie RA, Van Hemel S,
editors. Hearing Loss: Determining Eligibility for Social Security Benefits. Washington (DC): National Academies Press (US); 2004. Appendix A,
Definitions and Technical Terms. Available from: https://www.ncbi.nlm.nih.gov/books/NBK207847/
Garg S, Singh R, Khurana D. Infant Hearing Screening in India: Current Status and Way Forward. Int J Prev Med. 2015;6:113. Published 2015
Nov 19. doi:10.4103/2008-7802.170027
Consensus Statement of the Indian Academy of Pediatrics on Newborn Hearing Screening- 2017
Principles and Guidelines for Early Hearing Detection and Intervention Programs .Joint Committee on Infant Hearing .Pediatrics October
2007, 120 (4) 898-921; DOI: https://doi.org/10.1542/peds.2007-2333
Clinical Audio-Vestibulometry for Otologist and Neurologists- Anirban Biswas
Scott’s Brown Otorhinolaryngology Head and Neck Surgery.
https://ghr.nlm.nih.gov/ https://hereditaryhearingloss.org/pds
21. “NO CHILD IS TOO YOUNG TO BE EVALUATED FOR HEARING”
“SHOULD BE SUSPECTED WITHIN 1 MONTH, DIAGNOSED WITHIN 3 MONTH AND INTERVENED WITHIN
6 MONTHS OF AGE”
“EARLY IDENTIFICATION OF HEARING LOSS IS CRITICAL, NOT JUST FOR COMMUNICATION PURPOSES,
BUT FOR A CHILD TO REACH THEIR MAXIMUM HUMAN DEVELOPMENT AND SELF-ACTUALIZATION”
Thank you